Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Cash from Investing Activities for 6 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 91.01% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $113.0 million through Dec 2025, up 834.95% year-over-year, with the annual reading at $113.0 million for FY2025, 834.95% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $4.8 million at Lexicon Pharmaceuticals, down from $52.1 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $53.7 million in Q4 2024, with the low at -$110.2 million in Q1 2024.
  • Average Cash from Investing Activities over 3 years is $4.0 million, with a median of $13.8 million recorded in 2023.
  • Peak annual rise in Cash from Investing Activities hit 235.96% in 2024, while the deepest fall reached 1011.47% in 2024.
  • Over 3 years, Cash from Investing Activities stood at $51.9 million in 2023, then grew by 3.47% to $53.7 million in 2024, then plummeted by 91.01% to $4.8 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $4.8 million, $52.1 million, and $15.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.